These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 8950799)
1. The pathogenesis of the antiphospholipid syndrome. Greaves M; Hill MB; Phipps J; Hughes P; Ford I Thromb Haemost; 1996 Nov; 76(5):817-8. PubMed ID: 8950799 [No Abstract] [Full Text] [Related]
2. [Antiphospholipid-protein antibodies. Effects on the endothelium-platelet interaction]. Forastiero RR; Martinuzzo ME; Carreras LO Sangre (Barc); 1999 Jun; 44(3):223-30. PubMed ID: 10481585 [No Abstract] [Full Text] [Related]
3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [TBL] [Abstract][Full Text] [Related]
4. Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome. Meroni PL; Raschi E; Camera M; Testoni C; Nicoletti F; Tincani A; Khamashta MA; Balestrieri G; Tremoli E; Hess DC J Autoimmun; 2000 Sep; 15(2):237-40. PubMed ID: 10968917 [No Abstract] [Full Text] [Related]
5. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis. Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665 [TBL] [Abstract][Full Text] [Related]
6. Anti-beta 2-glycoprotein I antibodies and anti-endothelial cell antibodies induce tissue factor in endothelial cells. Kornberg A; Renaudineau Y; Blank M; Youinou P; Shoenfeld Y Isr Med Assoc J; 2000 Jul; 2 Suppl():27-31. PubMed ID: 10909414 [TBL] [Abstract][Full Text] [Related]
7. Anti-endothelial cell antibodies in primary antiphospholipid syndrome and SLE: patterns of reactivity with membrane antigens on microvascular and umbilical venous cell membranes. Hill MB; Phipps JL; Hughes P; Greaves M Br J Haematol; 1998 Nov; 103(2):416-21. PubMed ID: 9827913 [TBL] [Abstract][Full Text] [Related]
8. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941 [TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies--lobsters or red herrings? Rote NS; Walter A; Lyden TW Am J Reprod Immunol; 1992 Aug; 28(1):31-7. PubMed ID: 1418414 [No Abstract] [Full Text] [Related]
11. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. Harrison CN; Donohoe S; Carr P; Dave M; Mackie I; Machin SJ Thromb Haemost; 2002 May; 87(5):802-7. PubMed ID: 12038780 [TBL] [Abstract][Full Text] [Related]
12. Autoimmune antiphospholipid antibodies: what is their true target? Pengo V; Biasiolo A; Fior MG Haematologica; 1995; 80(2 Suppl):127-30. PubMed ID: 7628765 [No Abstract] [Full Text] [Related]
13. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity. Lackner KJ; von Landenberg C; Barlage S; Schmitz G Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321 [TBL] [Abstract][Full Text] [Related]
14. Anti-β₂-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile? Andreoli L; Nalli C; Motta M; Norman GL; Shums Z; Encabo S; Binder WL; Nuzzo M; Frassi M; Lojacono A; Avcin T; Meroni PL; Tincani A Ann Rheum Dis; 2011 Feb; 70(2):380-3. PubMed ID: 20971718 [TBL] [Abstract][Full Text] [Related]